Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-03-03

Clinical Trial Update: Study of LX6171 in Elderly Volunteers With Age Associated Memory Impairment [Phase 2]

View source ↗

Summary

Phase 2 study of LX6171 in elderly volunteers with age-related memory impairment completed; results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LX6171

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Age-Related Memory Disorders | Phase 2 | Status: COMPLETED | Results posted: 2010-03-03